Filing Details
- Accession Number:
- 0000908662-13-000104
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-27 16:15:43
- Reporting Period:
- 2013-02-25
- Filing Date:
- 2013-02-27
- Accepted Time:
- 2013-02-27 16:15:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 907562 | Dyax Corp | DYAX | Services-Commercial Physical & Biological Research (8731) | 043053198 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1279281 | Ivana Magovcevic | C/O Dyax Corp. 55 Network Drive Burlington MA 01803-2756 | Evp; Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-02-25 | 4,015 | $3.24 | 48,485 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.2200 to $3.2423, inclusive. The reporting person undertakes to provide to Dyax Corp., any security holder of Dyax Corp., or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1.
Billionaire Hedge Funds
